Edition:
United States

Immunovaccine Inc (IMV.TO)

IMV.TO on Toronto Stock Exchange

1.85CAD
23 Apr 2018
Change (% chg)

$0.04 (+2.21%)
Prev Close
$1.81
Open
$1.82
Day's High
$1.85
Day's Low
$1.77
Volume
111,925
Avg. Vol
112,245
52-wk High
$2.55
52-wk Low
$1.04

Select another date:

Thu, Jan 25 2018

BRIEF-Immunovaccine Announces $12.5 Million Bought Deal Offering

* IMMUNOVACCINE INC - ENTERED INTO BOUGHT DEAL FINANCING AGREEMENT TO SELL 6.3 MILLION COMMON SHARES AT A PRICE OF $2.00 PER COMMON SHARE Source text for Eikon: Further company coverage:

BRIEF-Immunovaccine announces positive clinical data from its collaborative combination immunotherapy trial in advanced ovarian cancer

* IMMUNOVACCINE ANNOUNCES POSITIVE CLINICAL DATA FROM ITS COLLABORATIVE COMBINATION IMMUNOTHERAPY TRIAL IN ADVANCED OVARIAN CANCER

BRIEF-IMMUNOVACCINE AND LEIDOS EXPAND COLLABORATION TO DEVELOP MALARIA VACCINE CANDIDATES

* IMMUNOVACCINE AND LEIDOS EXPAND COLLABORATION TO DEVELOP MALARIA VACCINES FORMULATED IN DEPOVAX Source text for Eikon: Further company coverage:

BRIEF-Immunovaccine reports qtrly loss per share of ‍$0.02​

* Immunovaccine announces third quarter 2017 financial results

BRIEF-Immunovaccine announces regulatory clearance for Phase 2 clinical trial evaluating DPX-Survivac

* Immunovaccine announces regulatory clearance for Phase 2 clinical trial evaluating DPX-Survivac in combination with Merck's checkpoint inhibitor Pembrolizumab in DLBCL Source text for Eikon: Further company coverage:

Select another date: